Maintenance medium for primate pluripotent stem cells

Inactive Publication Date: 2015-11-26
BOURBON CORP
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method for controlling the growth and maintenance of pluripotent stem cells using a medium containing xylose as a saccharide. This method allows for the inhibition of stem cell proliferation without the need for additional factors and can be used for short-term preservation and freezing sensitive stem cells. Xylose is a commonly available and cost-effective sugar. The method is simple to implement and requires no modification of the culture protocol for pluripotent stem cells.

Problems solved by technology

However, in pluripotent stem cells of primates including humans, it is not easy to grow the cells while maintaining the cell-specific properties, i.e., undifferentiation status and pluripotency (multipotency).
However, the passage process in culture in coexistence with feeder cells is complicated, and many of substances for maintaining undifferentiation status are expensive.
However, primate, especially human, ES cells and iPS cells are known to be sensitive to freezing and thawing and to have a low viability after cryopreservation.
Therefore, frequent cryopreservation cannot be performed for primate pluripotent stem cells.
Meanwhile, for human ES cells and iPS cells, it is difficult to prepare cells of different origin to a desired cell concentration during the same period because the growth rate is different by established cell line.
For human ES cells and iPS cells, it is recommended to change a medium every day due to their fast metabolism, and the risk of contamination is high, placing a burden on researchers.
However, in the field of culture cells, xylose has not been used as a saccharide in a medium because cells are considered not to be able to use xylose as energy.
However, these literatures have no description of primate pluripotent stem cells, which is remarkably sensitive to changes in culture environment compared with mouse ES cells.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Maintenance medium for primate pluripotent stem cells
  • Maintenance medium for primate pluripotent stem cells
  • Maintenance medium for primate pluripotent stem cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

Culture of Human iPS Cells (253G1 Lines and 201B7 Lines) in a Xylose Medium

(1) Preparation of Medium

[0063]A medium for human iPS cells (induced pluripotent stem cells) was prepared each so that the composition was as follows.

Control Medium (Glucose Medium for iPS Cells):

[0064]DMEM / F12 (Gibco BRL, Rockville, Md.), 20 volume % KSR (Invitrogen), 2 mM L-glutamine (Gibco), 1×MEM non-essential amino acid solution (Wako), 100 μM β-mercaptoethanol (Sigma, St. Louis, Mo.), 50 U / mL penicillin and 50 μg / mL streptomycin (Gibco BRL), and 4 ng / mL basic FGF (Invitrogen).

Medium According to Present Invention (Xylose Medium for iPS Cells):

[0065]Modified DMEM / F12 containing D-xylose at various concentrations in place of glucose contained in a normal DMEM / F12 (M-DMEM, available from Nissui Pharmaceutical Co., Ltd.), 20 volume % KSR (Invitrogen) or 20 volume % dialysed KSR (available from Nissui Pharmaceutical Co., Ltd.) in which sugars (saccharides) are removed by a dialysis membrane (dialysis membran...

example 2

Cell Proliferation Control of Human iPS Cells

[0086](Disease iPS Cells Derived from Ehlers-Danlos Syndrome Patients (P-iPS Cells))

(1) Preparation of Medium

[0087]A medium for human iPS cells (induced pluripotent stem cells) was prepared each so that the composition was as follows.

Control Medium (Glucose Medium for iPS Cells):

[0088]DMEM / F12 (Gibco BRL, Rockville, Md.), 20 volume % KSR (Invitrogen), 2 mM L-glutamine (Gibco), 1×MEM non-essential amino acid solution (Wako), 100 μM β-mercaptoethanol (Sigma, St. Louis, Mo.), 50 U / mL penicillin and 50 μg / mL streptomycin (Gibco BRL), and 4 ng / mL basic FGF (Invitrogen).

Medium According to Present Invention (Xylose Medium for iPS Cells):

[0089]Modified DMEM / F12 in which glucose contained in a normal DMEM / F12 is changed with D-xylose (M-DMEM, available from Nissui Pharmaceutical Co., Ltd.) (D-xylose concentration: 3.15 g / L), 20 volume % dialysed KSR (available from Nissui Pharmaceutical Co., Ltd.) in which sugars are removed by a dialysis membran...

example 3

Metabolites of Human iPS Cells in Xylose Medium

(1) Saccharide Consumption in Each Medium

[0097]iPS cells (253G1 lines) were cultured for 24 hours with a xylose medium for iPS cells or a glucose medium for iPS cells, the consumption of each saccharide (sugar) contained in the supernatant after culture was calculated. Measurement of each saccharide was performed with HPLC (manufactured by Shimadzu Corporation). When the amount at 0 hours after culture was defined as 100.0, the sugar amount was 79.0 for a glucose medium for iPS cells and 88.2 for a xylose medium for iPS cells, and when converted into sugar consumption (%), it was 21.1% and 11.8%, respectively.

(2) Confirmation of Metabolites

[0098]For metabolites in cell samples when iPS cells (253G1 lines) were cultured in a xylose medium for iPS cells, metabolome analysis were performed. Specifically, cell samples and culture supernatants were deproteinized by ultrafiltration, and the relative area of detected substances among metabolit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are a maintenance medium for primate pluripotent stem cells, and a method for preserving and a method for controlling proliferation of primate pluripotent stem cells using the medium. The maintenance medium for human pluripotent stem cells according to the present invention includes xylose as a saccharide.

Description

BACKGROUND OF THE INVENTION[0001]1. Field of the Invention[0002]The present invention relates to a maintenance medium for primate pluripotent stem cells, comprising xylose.[0003]2. Description of the Related Art[0004]Pluripotent stem cells such as human ES cells (embryonic stem cells) and iPS cells (induced pluripotent stem cells) have been expected to be used and applied in various fields including regenerative medicine and cell therapy because they have the ability to be differentiated into various cells or tissues such as nerve cells and cardiac muscle cells, i.e., pluripotency. Pluripotent stem cells can be grown by culture after cell establishment. However, in pluripotent stem cells of primates including humans, it is not easy to grow the cells while maintaining the cell-specific properties, i.e., undifferentiation status and pluripotency (multipotency).[0005]In order to grow human ES cells or human iPS cells while maintaining the undifferentiation status and the pluripotency, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N1/02
CPCC12N2501/00A01N1/0226A01N1/0221C12N5/0696C12N2500/34
Inventor MATSUSHIMA, AKITOTAKIZAWA, SAKIKOYOKOYAMA, TADAYUKI
Owner BOURBON CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap